B-LCL-HROC59 Cells
USD 800.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | B-LCL-HROC59 is an Epstein-Barr virus (EBV)-immortalized human B lymphoblastoid cell line generated from tumor-infiltrating B cells (TiBc) isolated from a primary colorectal carcinoma designated HROC59. The parental tumor was resected from an adult male patient with right-sided sporadic colorectal carcinoma and advanced-stage disease. Fresh tumor tissue was mechanically dissociated to obtain single-cell suspensions, and B cells were selectively immortalized in vitro using EBV-containing supernatant derived from the B95/8 marmoset cell line in the presence of cyclosporin A to suppress T- and NK-cell expansion. Long-term culture resulted in stable outgrowth of a monoclonal B-cell population, as demonstrated by immunoglobulin gene rearrangement analysis. B-LCL-HROC59 secretes immunoglobulin G (IgG) as its exclusive isotype, with stable production over prolonged culture. In cell-based binding assays, IgG derived from B-LCL-HROC59 demonstrated only minimal binding to tested allogeneic colorectal carcinoma cell lines compared with other TiBc-derived IgGs exhibiting stronger tumor cell reactivity. No evidence of spontaneous B-cell outgrowth was observed in the absence of exogenous EBV during culture establishment, indicating that immortalization occurred in vitro rather than reflecting latent EBV-driven transformation in vivo. As a monoclonal, antigen-experienced tumor-infiltrating B-cell line, B-LCL-HROC59 provides a defined model for studying humoral immune responses within the colorectal cancer microenvironment and for investigating the specificity and functional properties of tumor-associated antibodies. |
|---|---|
| Organismo | Human |
| Tejido | Peripheral blood |
| Enfermedad | Carcinoma |
| Sinónimos | Bc HROC59, TiBcHROC59 |
Características
| Edad | 76 years |
|---|---|
| Género | Male |
| Origen étnico | Caucasian |
| Morfología | Round cells |
| Tipo de célula | B lymphoblast |
| Propiedades de crecimiento | Suspension |
Datos normativos
| Referencia | B-LCL-HROC59 (Cytion catalog number 302073) |
|---|---|
| Nivel de bioseguridad | 2 |
| NCBI_TaxID | 9606 |
| N.º de acceso de Cellosaurus | CVCL_A7US |
Datos biomoleculares
| Antígenos de superficie | CD19 |
|---|---|
| Virus | Transformant: EBV |
Manejo
| Medio de cultivo | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suplementos | Supplement the medium with 10% heat-inactivated FBS |
| Subcultivo | Gently homogenize the cell suspension in the flask by pipetting up and down, then take a representative sample to determine the cell density per ml. Dilute the suspension to achieve a cell concentration of 1 x 105 cells/ml with fresh culture medium, and aliquot the adjusted suspension into new flasks for further cultivation. |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
| Esterilidad | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|